This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT01676935 · TERMINATED
Trial details
- NCT number
- NCT01676935
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-03-01
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.